An observational study in Travel Medicine, sponsored by University of Waterloo. Completed at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-01-19.
Sponsored by University of Waterloo · Observational
This study will evaluate the clinical effectiveness of, and patient satisfaction with, pre-travel consultations provided by a pharmacist with specialty training in travel medicine and the authorization to prescribe medications and administer vaccinations.
The study will be conducted at the Travel Health Network, a full-service travel medicine clinic located in St. Albert, Alberta. Care will be provided by a pharmacist with a specialized practice in travel medicine, authorization to prescribe vaccines and prescription drugs, and authorization to administer vaccines by injection.
The study will be a prospective mixed-methods cohort study, describing patients receiving care from a pharmacist-managed travel medicine clinic and their travel health needs, and evaluating their adherence to recommended vaccines and oral therapies, satisfaction with the care provided, and their health status and management of health issues arising while travelling. Chart reviews will elicit descriptive quantitative data related to patients' travel medicine needs and adherence to recommended vaccinations and oral pharmacotherapy, followed by surveys containing open-ended qualitative questions to elicit overall patient satisfaction and the management of any health issues encountered during travel. Due to the nature of the study involving patients presenting to the clinic for a consultation, neither a control group nor blinding is possible.
A convenience sample of 100 subjects will be enrolled.
University of Waterloo is the lead sponsor of 90 studies on the registry; 8 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 9 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
The study population will consist of individuals presenting for travel consultations at the Travel Health Network. No restrictions will be placed related to patient demographics, destinations, or travel itineraries; however, travellers with an expected return date after September 1, 2016 will be excluded, to ensure complete follow-up and data analysis within the proposed project time frame. A convenience sample of 100 patients will be consecutively enrolled .
Exclusion Criteria:
Other: Pharmacist-provided travel care
Subjects will receive a pre-travel consultation from a pharmacist with specialty training in travel medicine, and with authorization to prescribe medications and vaccines and administer injections
The proportion of recommended pre-travel vaccinations administered before departure according to chart review
From date of pre-travel consultation until the date of travel departure according to participant's planned itinerary, assessed up to September 2016.
Time frame: Up to 7 months.
The proportion of recommended pre-travel oral pharmacotherapies dispensed before departure by a community pharmacy according to electronic health record
From date of pre-travel consultation until the date of travel departure according to participant's planned itinerary, assessed up to September 2016.
Time frame: Up to 7 months.
Average satisfaction (along 1-5 scale) with care provided elicited through an online survey post-travel
Time frame: 1 week following return from travel according to participant's planned itinerary
Frequency of reason(s) for declining any recommended vaccines or medications according to participant self-report through an online survey
Response options: didn't feel I was at risk, cost, concern about vaccine ingredients or safety, other (specify)
Time frame: 1 week following return from travel according to participant's planned itinerary
Number of reports of any health issues over the course of travel according to participant self-report through an online survey
Response options: Traveller's diarrhea, Altitude sickness, Malaria, Fever (Dengue, Chikungunya), Respiratory illness, Other (specify)
Time frame: 1 week following return from travel according to participant's planned itinerary
Frequency of management strategies of any health issues over the course of travel according to participant self-report through an online survey
Response options: Nothing - it went away on its own, Took a non-prescription medication I had purchased before departure, Took a non-prescription medication I purchased while travelling, Called or emailed the Travel Health Network for advice, Searched the internet for guidance on how to manage it, Saw a physician while travelling, Saw a physician upon returning home, Other (specify)
Time frame: 1 week following return from travel according to participant's planned itinerary
This study is completed, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Waterloo